// App-Quantinova.ai

3610 : Evaluating longitudinal toxicity of cetuximab in patients with metastatic colorectal cancer (mCRC): A pooled analysis from 1,302 patients in the ARCAD database.

Researchers

Presenter

  • Guilherme Lopes

Principal Investigators

  • Jane Yeojeong So

  • Katrin Marie Sjoquist

  • Curtis L. Olswold

  • Eric Van Cutsem

  • Carsten Bokemeyer

  • Richard Adams

  • Benoist Chibaudel

  • Axel Grothey

  • Takayuki Yoshino

  • Aimery De Gramont

  • Qian Shi

  • Christophe Tournigand

  • John Raymond Zalcberg

Medical Centers

  • Mayo Clinic, Rochester, MN, Auckland City Hospital, Auckland, New Zealand

  • NHMRC Clinical Trials Centre, The University of Sydney, Sydney, Australia

  • University Hospitals Leuven and KU Leuven, Leuven, Belgium

  • University Medical Center Hamburg Eppendorf, Hamburg, Germany

  • Cardiff University and Velindre Cancer Centre, Cardiff, United Kingdom

  • Franco-British Institute, Levallois-Perret, France

  • West Cancer Center, OneOncology, Germantown, TN, National Cancer Center Hospital East, Kashiwa, Japan

  • Hôpital Henri Mondor, Assistance Publique-Hôpitaux de Paris,...

  • France

  • Peter MacCallum Cancer Centre, East Melbourne, Australia

Locations

  • New Zealand

  • Australia

  • Belgium

  • Germany

  • United Kingdom

  • France

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Dermatology

  • Oncology (ONC)

  • Gastroenterology (GU)

Disease

  • Colorectal Cancer

  • Hand foot syndrome

  • Mucositis

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Erbitux

  • FOLFIRI

  • Oxaliplatin, 5-fluorouracil and folic acid

Outcome

  • N/A

Study Design

  • Randomized

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved